Yale University

Naltrexone Helps Ex-Prisoners With Substance Use Disorders Succeed on HIV Meds

People who are incarcerated, living with HIV and have a substance use disorder are more likely to be virally suppressed six months after leaving prison or jail if they are given monthly injections of long-acting naltrexone. Sandra Springer, MD, an associate professor at the Yale School of Medicine, presented findings from a pair of double-blind placebo-controlled studies of HIV-positive individuals emerging from incarceration at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston. Springer noted that the number one cause of death among individuals re-entering the community after incarceration is relapse of opiate addiction.

More from POZ

Published: Friday, March 9, 2018